Accuracy of Transcranial Doppler for the Diagnosis of Intracardiac Right-to-Left Shunt A Bivariate Meta-Analysis of Prospective Studies by Mojadidi, M. Khalid et al.
J A C C : C A R D I O V A S C U L A R I M A G I N G V O L . 7 , N O . 3 , 2 0 1 4
ª 2 0 1 4 B Y T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N D A T I O N I S S N 1 9 3 6 - 8 7 8 X / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c m g . 2 0 1 3 . 1 2 . 0 1 1Accuracy of Transcranial Doppler for the
Diagnosis of Intracardiac Right-to-Left Shunt
A Bivariate Meta-Analysis of Prospective Studies
M. Khalid Mojadidi, MD,* Scott C. Roberts, BS,* Jared S. Winoker, BS,* Jorge Romero, MD,*
David Goodman-Meza, MD,* Rubine Gevorgyan, MD,y Jonathan M. Tobis, MDy
Bronx, New York; and Los Angeles, CaliforniaOBJECTIVES The aim of this meta-analysis was to determine the accuracy of transcranial Doppler
(TCD) compared with transesophageal echocardiography (TEE) as the reference.
BACKGROUND Right-to-left shunting (RLS), usually through a patent foramen ovale (PFO), has been
associated with migraine, cryptogenic stroke, and hypoxemia. With emerging observational studies and
clinical trials on the subject of PFO, there is a need for accurate diagnosis of PFO in patients with these
conditions, and those being considered for transcatheter closure. Although a TEE bubble study is the
current standard reference for diagnosing PFO, the TCD bubble study may be a preferable alternative
test for RLS because of its high sensitivity and speciﬁcity, noninvasive nature, and low cost.
METHODS A systematic review of Medline, the Cochrane Library, and Embase was done to look for
all the prospective studies assessing intracardiac RLS using TCD compared with TEE as the reference;
both tests were performed with a contrast agent and a maneuver to provoke RLS in all studies.
RESULTS A total of 27 studies (29 comparisons) with 1,968 patients (mean age 47.8  5.7 years; 51%
male) fulﬁlled the inclusion criteria. The weighted mean sensitivity and speciﬁcity for TCD were 97% and
93%, respectively. Likewise, the positive and negative likelihood ratios were 13.51 and 0.04, respectively.
When 10 microbubbles was used as the embolic cutoff for a positive TCD study, TCD produced a higher
speciﬁcity compared with when 1 microbubble was used as the cutoff (p ¼ 0.04); there was, however, no
signiﬁcant change in sensitivity (p ¼ 0.29).
CONCLUSIONS TCD is a reliable, noninvasive test with excellent diagnostic accuracies, making it a
proﬁcient test for detecting RLS. TCD can be used as a part of the stroke workup and for patients being
considered for PFO closure. If knowledge of the precise anatomy is required, then TEE can be obtained
before scheduling a patient for transcatheter PFO closure. (J Am Coll Cardiol Img 2014;7:236–50)
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237atent foramen ovale (PFO) is a remnant of were omitted because they would not have enough
the fetal circulation that is present in 20%A B B R E V I A T I O N S
A N D A C R O N YM S
CI = conﬁdence interval
FN = false negativeto 25% of the population (1–3). Transient
right-to-left shunting (RLS), usually through
a PFO, has been implicated in the pathophysiology
of stroke, migraine, and hypoxemia (3–6). A meta-
analysis of observational studies and a recent meta-
analysis of the CLOSURE 1 (Closure or Medical
Therapy for Cryptogenic Stroke with Patent Fora-
men Ovale), RESPECT (Closure of Patent Foramen
Ovale Versus Medical Therapy After Cryptogenic
Stroke), and PC (Percutaneous Closure of Patent
Foramen Ovale in Cryptogenic Embolism) trials
suggest that PFO occluding devices reduce the
recurrence of stroke and transient ischemic attack at
higher rates than conventional medical treatment
alone (pooled hazard ratio: 0.59, 95% conﬁdence
interval [CI]: 0.36 to 0.97; p ¼ 0.04) (7,8). These
data, along with the evaluation of patients with severe
migraines or other PFO-associated conditions, make
it essential to accurately diagnose RLS in patients
being considered for PFO closure.See page 251
FP = false positive
LR = likelihood ratio
MCA = middle cerebral artery
PFO = patent foramen ovale
QUADAS = Quality Assessment
of Diagnostic Accuracy Studies
RLS = right-to-left shunt
ROC = receiver-operating
characteristic
TCD = transcranial Doppler
TEE = transesophageal
echocardiography
TN = true negativeWhereas contrast transesophageal echocardiogra-
phy (TEE) is considered the gold standard for
diagnosing PFO (9,10), contrast transcranial
Doppler (TCD) is increasingly being used for safe,
noninvasive, and cost-effective screening of intra-
cardiac RLS (11–37). The aim of this study was to
expand on prior reviews of TCD to provide the
ﬁrst meta-analysis that methodically assesses the
diagnostic accuracy of TCD in evaluating for an
intracardiac RLS.TP = true positiveMETHODS
Literature review. Relevant citations were searched
for on Medline, the Cochrane Library, and
Embase. The search was completed in August 2013,
yielding literature since 1913. The terms used in the
search were “PFO” OR “patent foramen ovale” OR
“right to left shunt” OR “atrial septal defect” AND
“TCD” OR “transcranial Doppler” OR “TEE” OR
“echo” OR “transesophageal echo” OR “trans-
esophageal echocardiogram” OR “transesophageal
echocardiography.”
The references of all primary studies as well as
those from known reviews were analyzed to ﬁnd
cited studies that were not found by initial searches.
No restrictions were used regarding publication lan-
guage. Abstracts lacking peer-reviewed manuscriptsdata required for the meta-analysis.
Selection of studies. Studies that were identiﬁed
were analyzed by 3 independent reviewers (M.K.M.,
S.C.R., and J.S.W.). Each study was screened for
pre-set inclusion criteria:
1. Original prospective studies (reviews, ab-
stracts, isolated cases, commentaries, edito-
rials, and letters were excluded)
2. Subject age $18 years
3. Studies were selected if they included at least
20 patients with suspected intracardiac RLS
who were screened by TCD and conﬁrmed by
TEE as a reference. If a study conducted both
TCD and TEE, but did not consider TEE as
the gold standard, we calculated the appro-
priate parameters assuming TEE as
the reference comparison.
4. TCD and TEE accuracies calculated
utilizing a provocation maneuver.
5. Able to interpret diagnostic accu-
racies by adequate demonstration of
true positives (TP), true negatives
(TN), false positives (FP), and false
negatives (FN).
6. If a study compared different TCD
protocols (such as comparing accu-
racy of different contrast injection
sites or different types of contrast)
and also provided the variables to
calculate the different accuracies (i.e.,
the TP, FP, FN, and TN), then each
methodology was considered a sepa-
rate comparison in the ﬁnal analysis.
A sensitivity analysis was then con-
ducted to demonstrate the effect of
varying methodologies on accuracy of TCD.
Data extraction. The data were extracted onto a
spreadsheet with information regarding study
design, cohort size, age, sex, TCD/TEE indication,
contrast type, method of provocation (Valsalva
maneuver or cough), microbubble cutoff used for a
positive TCD/TEE study, and test accuracy results
(TP, FP, FN, and TN).
Quality assessment. The quality of each study was
assessed by evaluating items considered relevant to
the review topic, on the basis of the Quality
Assessment of Diagnostic Accuracy Studies (version
2) instrument (QUADAS-2) (38). Three reviewers
(M.K.M., S.C.R., and J.R.) independently assessed
the quality items, and discrepancies were resolved by
consensus.
Figure 1. Selection of Studies
Of 174,961 records identiﬁed, 27 were included in the meta-analysis. Twenty-six studies did not meet the inclusion criteria and were excluded.
cath ¼ catheterization; RLS ¼ right-to-left shunt; TCD ¼ transcranial Doppler; TTE ¼ transthoracic echocardiogram.
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238Statistical analysis. Sensitivities and speciﬁcities
were calculated for every study using a more recently
developed bivariate random effects model (39). The
bivariate approach assumed that logit transforms of
sensitivity and speciﬁcity from individual studies are
from a bivariate normal distribution. The bivariate
approach is considered superior to the standard
summary receiver-operating characteristic (ROC)
approach (40) because: 1) it assesses heterogeneity
across studies, providing a summary estimate of
sensitivity and speciﬁcity; 2) it models sensitivity
and speciﬁcity jointly so that a 95% conﬁdence el-
lipse around the summary estimate can be calcu-
lated; 3) it allows calculation of positive and negative
likelihood ratios; 4) it allows one to directly compare
sensitivity and speciﬁcity between methods; and
5) several choices are available to obtain a sum-
mary ROC curve (39). In this study, the summary
ROC curve was obtained by transforming theregression line of logit sensitivity on logit speci-
ﬁcity into ROC space. Publication bias was
assessed for each analysis using Deeks’s method
(41). Post-test probabilities were calculated using
Bayes’ normogram, which requires converting
pre-test probabilities to odds and backtracking
post-test odds to probabilities.
We assessed between-study heterogeneity visu-
ally, by plotting sensitivity and speciﬁcity in the
ROC curves (42). The analyses were conducted
using STATA 12 (Metandi Syntax, StataCorp LP,
College Station, Texas), and the ﬁgures were
generated using STATA graph editor.
SENSITIVITY ANALYSIS. We further evaluated
whether the performance of each technique depends
on features of the technique and patient character-
istics. A logistic regression for each technique was
used to model the sensitivity of these factors.
Figure 2. Assessment of Publication Bias Using Deeks’s Method
Deeks’ funnel plot asymmetry test for publication bias. Signiﬁcant asymmetry (p < 0.10)
indicates presence of publication bias. ESS ¼ effective sample size.
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239RESULTS
Study selection. We identiﬁed 174,961 reports, of
which 53 studies were considered for detailed
evaluation and 27 studies met the inclusion criteria
(11–37). Two studies demonstrated 2 different ac-
curacies for TCD by comparing different protocols;
we therefore included 29 comparisons in our ﬁnal
analysis consisting of 1,968 patients (mean age
47.8  5.7 years; 51% male).
Twenty-six studies were excluded from the ﬁnal
analysis because they did not meet the inclusion
criteria; the excluded studies, along with the reasons
for exclusion, are provided in the Online Appendix.
Figure 1 describes the study selection method used
for this analysis.
Publication bias. There was no publication bias us-
ing Deeks’s method, with a p value of 0.51 (Fig. 2).
Quality assessment. Using the items for evaluating
diagnostic studies with QUADAS-2, the risk of
bias and applicability concerns for all the studies
were assessed (Fig. 3). Most studies had high
methodological quality with very minimal concerns
regarding applicability of the test in clinical practice
(Fig. 3). Uninterpretable results and withdrawals
that represented the “ﬂow and timing” section were
unclear in 86% (25 of 29) of the comparisons. Data
on these 2 parameters are often not reported in
diagnostic accuracy studies, with the uninterpretable
results and withdrawals simply removed from the
analysis. This may lead to a biased assessment of
test characteristics. Whether or not bias will arise
depends on the possible correlation between unin-
terpretable test results and the true disease status.
Uninterpretable results frequently occur randomly
and are unrelated to the true disease status of the
individual. Therefore, in theory, these should not
have any effect on test performance. Likewise, 3 of
29 comparisons (10%) were not conducted in a
blinded fashion; this may have led to review bias in
these particular studies. Some did not clearly specify
whether blinding occurred in the index or reference
tests. A review bias may potentially lead to inﬂated
measures of diagnostic accuracy.
Transcranial Doppler. A total of 29 comparisons
met all inclusion criteria and were used for further
meta-analytic calculations. Table 1 describes the
characteristics of the included studies, and Table 2
describes the diagnostic accuracies of the studies.
The major clinical indication for performing a TCD
in most of the studies was stroke followed by
migraine headache. Of the 29 comparisons that
performed TCD and TEE with contrast, 12 (41%)
used agitated saline as the contrast agent, 10 (35%)used Echovist (Schering, Berlin, Germany), 4 (14%)
used a gelatin-based solution, and 3 (10%) used 2
different contrast agents. The Valsalva maneuver
was used as the provocation method in 86% (25 of 29)
of the comparisons, Valsalva with cough was used in
10% (3 of 29), and the provocation method used
was unknown in 3% (1 of 29) of the comparisons.
The majority of the comparisons used $1 micro-
bubble as the embolic cutoff for a positive TCD
(62%; 18 of 29) or TEE (52%; 15 of 29).
When all eligible studies were pooled into the
diagnostic accuracy meta-analysis, the sensitivity of
TCD for the diagnosis of intracardiac RLS was
97.0% (95% CI: 94.0% to 98.0%; I2 ¼ 71.02%)
(Fig. 4A), the speciﬁcity was 93.0% (95% CI: 86.0%
to 97.0%; I2 ¼ 89.8%) (Fig. 4B), the positive like-
lihood ratio (LRþ) was 13.51 (95% CI: 6.54% to
27.92%; I2 ¼ 89.1%) (Fig. 5A), and the negative
likelihood ratio (LR) was 0.04 (95% CI: 0.02% to
0.07%; I2 ¼ 69.3%) (Fig. 5B). The studies were
heterogeneous in their estimates of sensitivity, spec-
iﬁcity, LRþ, and LR (p < 0.01). The hierarchical
summary ROC curves are illustrated in Figure 6.
We performed a sensitivity analysis for different
contrast agents used, different provocation maneuvers,
different microembolic cutoffs for a positive index
(TCD) and reference test (TEE), different timings of
provocation maneuver, and unilateral versus bilateral
middle cerebral artery (MCA) insonation (Table 3).
Figure 3. Methodological Quality Summary: QUADAS-2
(A) Risk of bias and applicability concerns graph: review authors’ judgments about each domain presented as percentages across included studies. (B) Risk
of bias and applicability concerns summary: review authors’ judgments about each domain for each included study. QUADAS-2 ¼ Quality Assessment of
Diagnostic Accuracy Studies version 2.
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Table 1. Characteristics of the Included Studies
First Author, Year (Ref. #)
Majority
Disease Subjects
Mean Age
(yrs) Males Contrast
Provocation/
Duration
MB Cutoff
for Positive
TCD
MB Cutoff
for Positive
TEE
MCA
Insonation
Albert et al., 1997 (17) Stroke 69 44.0 28 (41) Saline or gelatin VM & cough/NS $10 NS Unilateral
Belvís et al., 2006 (30) Stroke 110 56.7 67 (61) Saline VM/10 s $1 $3 Unilateral
Blersch et al., 2002 (26) Stroke 40 47.9 23 (58) Echovist VM/10 s $1 $1 Unilateral
Caputi et al., 2009 (32) Stroke 100 46.0 41 (41) Saline VM/NS $3 $1 Unilateral
Devuyst et al., 1997 (18) Stroke 37 46.0 24 (62) Saline VM/NS $3 $3 Bilateral
Droste et al., 1999 (22) Stroke 54 44.0 38 (70) Echovist or saline VM/5 s $1 $1 Bilateral
Droste et al., 1999 (23) Stroke 46 47.0 20 (43) Echovist or saline VM/5 s $1 $1 Bilateral
Droste et al., 2002 (27) Stroke 64 47.0 46 (72) Echovist VM/5 s $1 $1 Bilateral
Droste et al., 2002 (28)* Stroke 81 48.7 50 (62) Echovist VM/5 s $1 $1 Bilateral
Droste et al., 2002 (28)y Stroke 81 48.7 50 (62) Saline VM/5 s $1 $1 Bilateral
Ferrarini et al., 2005 (29) Migraine 25 40.0 8 (32) Saline VM/10 s $1 $3 Unilateral
González-Alujas et al., 2011 (37) Stroke 134 46.4 75 (56) Saline VM/>5 s NS NS NS
Hamann et al., 1998 (20)z Stroke 44 34.7 18 (41) Echovist VM/2 s $10 $5 Bilateral
Hamann et al., 1998 (20)x Stroke 44 34.7 18 (41) Echovist VM/2 s $10 $5 Bilateral
Heckmann et al., 1999 (24) Stroke 45 41.4 24 (53) Echovist VM/NS >5 >5 Unilateral
Horner et al., 1997 (19) Stroke 45 41.0 21 (47) Echovist VM/>5 s $1 $1 Bilateral
Jauss et al., 1994 (15) Stroke 50 54.3 37 (74) Echovist VM/5 s $1 $1 NS
Job et al., 1994 (14) Stroke 137 36.0 76 (55) Gelatin VM & cough/NS $1 $1 Unilateral
Karnik et al., 1992 (12) Stroke 36 61.0 20 (55) Gelatin VM/NS $5 $1 Bilateral
Klötzsch et al., 1994 (16) Stroke 111 58.9 77 (69) Echovist VM/NS NS $3 Unilateral
Maffè et al., 2010 (35) Stroke 75 49.0 28 (37) Saline VM/NS $1 $1 Unilateral
Nemec et al., 1991 (11) Stroke 32 50.0 14 (44) Saline NS/NS $1 $1 Unilateral
Nygren et al., 1998 (21) Stroke 23 56.0 16 (70) Gelatin VM/NS $1 NS Unilateral
Orzan et al., 2010 (36) Stroke 68 49.0 38 (56) Saline VM/NS $1 $20 Bilateral
Sastry et al., 2009 (33) Stroke 39 39.0 18 (46) Saline VM & cough/5 s >15 >3 Bilateral
Souteyrand et al., 2006 (31) Stroke 107 56.0 67 (63) Saline VM/10 s $1 $1 Unilateral
Stendel et al., 2000 (25) Neurosurgery 92 51.0 47 (51) Echovist VM/5 s NS NS Bilateral
Venketasubramanian
et al., 1993 (13)
Stroke 49 62.7 27 (55) Saline VM/NS $1 NS Unilateral
Zito et al., 2009 (34) Stroke &
migraine
72 49.0 33 (46) Gelatin VM/10 s $1 $1 Unilateral
Values are n or n (%). *Echovist used as contrast agent. ySaline used as contrast agent. zContrast was injected via the femoral vein. xContrast was injected via the antecubital vein.
MB ¼ microbubble; MCA ¼ middle cerebral artery; NS ¼ not speciﬁed; TCD ¼ transcranial Doppler; TEE ¼ transesophageal echocardiography; VM ¼ Valsalva maneuver.
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241There was no signiﬁcant difference in sensitivity or
speciﬁcity when different contrast agents (agitated
saline, Echovist, and gelatin-based solutions) were
utilized (p > 0.05). However, there was a trend to-
wards Echovist producing a higher sensitivity (95%
sensitivity) compared with when gelatin-based solu-
tions (94% sensitivity) were used (p ¼ 0.06). Studies
that used Valsalva with cough did not produce a
higher sensitivity or speciﬁcity compared with studies
that only used Valsalva as their provocation maneuver
(p > 0.7). When 10 microbubbles was used as the
embolic cutoff for a positive TCD study, TCD pro-
duced a higher speciﬁcity compared with when 1microbubble was used as the cutoff (p ¼ 0.04); there
was, however, no signiﬁcant change in sensitivity (p¼
0.29). There was no signiﬁcant difference in sensi-
tivity or speciﬁcity between studies that used 1
microbubble compared with studies that used 3
microbubbles as the cutoff for a positive TEE (p >
0.1). There were no signiﬁcant differences in sensi-
tivity or speciﬁcity in studies that performed the
provocation maneuver for #5 s compared with >5 s
(p > 0.50). Lastly, there was a trend towards inso-
nation of the unilateral MCA producing a higher
speciﬁcity (95% speciﬁcity) compared with when
bilateral MCA insonation (89% speciﬁcity) was used
Table 2. Accuracies of the Included Studies
First Author, Year (Ref. #) TP FP FN TN Sen (95% CI) Spec (95% CI) LRD (95% CI) LRL (95% CI)
Albert et al., 1997 (17) 25 0 0 33 1.00 (0.86–1.00) 1.00 (0.89–1.00) 66.69 (4.26–1045.20) 0.02 (0.00–0.30)
Belvís et al., 2006 (30) 36 0 0 74 1.00 (0.90–1.00) 1.00 (0.95–1.00) 147.97 (9.34–2344.51) 0.01 (0.00–0.21)
Blersch et al., 2002 (26) 21 2 2 15 0.91 (0.72–0.99) 0.88 (0.64–0.99) 7.76 (2.10–28.70) 0.10 (0.03–0.37)
Caputi et al., 2009 (32) 61 8 2 29 0.97 (0.89–0.89) 0.78 (0.62–0.90) 4.48 (2.42–8.28) 0.04 (0.01–0.16)
Devuyst et al., 1997 (18) 24 5 0 8 1.00 (0.86–1.00) 0.62 (0.32–0.86) 2.49 (1.30–4.80) 0.03 (0.00–0.53)
Droste et al., 1999 (22) 18 6 1 29 0.95 (0.74–1.00) 0.83 (0.66–0.93) 5.53 (2.65–11.54) 0.06 (0.01–0.43)
Droste et al., 1999 (23) 20 10 0 16 1.00 (0.83–1.00) 0.62 (0.41–0.80) 2.51 (1.56–4.05) 0.04 (0.00–0.61)
Droste et al., 2002 (27) 27 15 0 22 1.00 (0.87–1.00) 0.59 (0.42–0.75) 2.41 (1.64–3.54) 0.03 (0.00–0.48)
Droste et al., 2002 (28)* 31 22 0 28 1.00 (0.89–1.00) 0.56 (0.41–0.70) 2.23 (1.63–3.05) 0.03 (0.00–0.44)
Droste et al., 2002 (28)y 29 22 2 28 0.94 (0.79–0.99) 0.56 (0.41–0.70) 2.13 (1.53–2.95) 0.12 (0.03–0.45)
Ferrarini et al., 2005 (29) 18 4 0 3 1.00 (0.81–1.00) 0.43 (0.10–0.82) 1.73 (0.94–3.20) 0.06 (0.00–1.04)
González-Alujas et al., 2011 (37) 80 10 2 42 0.98 (0.91–1.00) 0.81 (0.67–0.90) 5.07 (2.90–8.86) 0.03 (0.01–0.12)
Hamann et al., 1998 (20)z 22 0 0 22 1.00 (0.85–1.00) 1.00 (0.85–1.00) 45.00 (2.90–698.44) 0.02 (0.00–0.34)
Hamann et al., 1998 (20)x 6 0 2 36 0.75 (0.35–0.97) 1.00 (0.90–1.00) 53.44 (3.31–863.78) 0.28 (0.10–0.81)
Heckmann et al., 1999 (24) 22 0 4 19 0.85 (0.65–0.96) 1.00 (0.82–1.00) 33.33 (2.15–517.34) 0.17 (0.07–0.40)
Horner et al., 1997 (19) 34 3 1 7 0.97 (0.85–1.00) 0.70 (0.35–0.93) 3.24 (1.25–8.36) 0.04 (0.01–0.29)
Jauss et al., 1994 (15) 14 0 1 35 0.93 (0.68–1.00) 1.00 (0.90–1.00) 65.25 (4.14–1027.85) 0.10 (0.02–0.44)
Job et al., 1994 (14) 58 6 7 66 0.89 (0.79–0.96) 0.92 (0.83–0.97) 10.71 (4.95–23.14) 0.12 (0.06–0.24)
Karnik et al., 1992 (12) 13 0 2 21 0.87 (0.60–0.98) 1.00 (0.84–1.00) 37.12 (2.38–579.71) 0.16 (0.05–0.50)
Klötzsch et al., 1994 (16) 42 4 4 61 0.91 (0.79–0.98) 0.94 (0.85–0.98) 14.84 (5.72–38.50) 0.09 (0.04–0.24)
Maffè et al., 2010 (35) 53 1 9 12 0.85 (0.74–0.93) 0.92 (0.64–1.00) 11.11 (1.69–73.26) 0.16 (0.08–0.29)
Nemec et al., 1991 (11) 13 3 0 16 1.00 (0.75–1.00) 0.84 (0.60–0.97) 5.51 (2.12–14.35) 0.04 (0.00–0.66)
Nygren et al., 1998 (21) 10 2 0 9 1.00 (0.69–1.00) 0.82 (0.48–0.98) 4.58 (1.51–13.91) 0.06 (0.00–0.87)
Orzan et al., 2010 (36) 6 15 0 47 1.00 (0.54–1.00) 0.76 (0.63–0.86) 3.77 (2.34–6.09) 0.09 (0.01–1.37)
Sastry et al., 2009 (33) 16 0 0 23 1.00 (0.79–1.00) 1.00 (0.85–1.00) 46.59 (3.00–724.43) 0.03 (0.00–0.46)
Souteyrand et al., 2006 (31) 42 6 0 59 1.00 (0.92–1.00) 0.91 (0.81–0.97) 10.04 (4.83–20.84) 0.01 (0.00–0.20)
Stendel et al., 2000 (25) 22 0 2 68 0.92 (0.73–0.99) 1.00 (0.95–1.00) 124.20 (7.82–1971.85) 0.10 (0.03–0.33)
Venketasubramanian et al., 1993 (13) 12 0 0 37 1.00 (0.74–1.00) 1.00 (0.91–1.00) 73.08 (4.65–1149.60) 0.04 (0.00–0.59)
Zito et al., 2009 (34) 45 1 1 25 0.98 (0.88–1.00) 0.96 (0.80–1.00) 25.43 (3.72–173.90) 0.02 (0.00–0.16)
*Echovist used as contrast agent. ySaline used as contrast agent. zContrast was injected via the femoral vein. xContrast was injected via the antecubital vein.
CI ¼ conﬁdence interval; FN ¼ false negative; FP ¼ false positive; LRþ ¼ positive likelihood ratio; LR ¼ negative likelihood ratio; Sen ¼ sensitivity; Spec ¼ speciﬁcity; TN ¼ true negative;
TP ¼ true positive.
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242(p ¼ 0.09). There was no signiﬁcant difference in
sensitivity between unilateral and bilateral MCA
insonation (p ¼ 0.15).
Figure 7 demonstrates the pre- and post-test
probabilities of detecting an intracardiac RLS with
TCD in the general population, and in our study
cohort consisting mainly of patients with stroke or
migraine. Because PFO is present in 20% to 25% of
the adult population and in approximately 50% to
55% of patients with migraine or cryptogenic stroke
(1–3,14), these respective prevalences were assumed
to demonstrate the likelihood of detecting a RLS by
TCD in the 2 populations.With a LRþ of 14 and LR of 0.04, a TCD
performed in the general population consisting of a
20% RLS prevalence will have 77% probability of a
positive result being a TP and a 1% probability of
a negative result being a FN (Fig. 7A). These
probabilities signiﬁcantly change in a population of
patients with stroke or migraine who undergo
TCD. With a LRþ of 14 and LR of 0.04, a TCD
performed in patients with migraine or stroke con-
sisting of a 50% to 55%% RLS prevalence will have
93% to 94% probability of a positive result being a
TP and a 4% probability of a negative result being a
FN (Figs. 7B and 7C).
Figure 4. Forest Plots of the Sensitivity and Speciﬁcity of Each Study
Forest plots of sensitivity (A) and speciﬁcity (B). Size of the square plotting symbol is proportional to the sample size for each study.
Horizontal lines are the 95% conﬁdence intervals (CI), and the summary sensitivity and speciﬁcity are calculated on the basis of the bivariate
approach.
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Figure 5. Forest Plots of the Positive and Negative Likelihood Ratio of Each Study
Forest plots of positive (A) and negative (B) likelihood ratios. Size of the square plotting symbol is proportional to the sample size for each
study. Horizontal lines are the 95% conﬁdence intervals (CI), and the summary sensitivity and speciﬁcity are calculated on the basis of the
bivariate approach. DLR ¼ diagnostic likelihood ratio.
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Figure 6. HSROC Plot
On the basis of combined sensitivity and speciﬁcity weighted for sample size of each
dataset reﬂected by the size of the open circles, showing average sensitivity and speciﬁcity
estimate of the study results (solid square) and 95% conﬁdence region around it. The 95%
prediction region represents the conﬁdence region for a forecast of the true sensitivity and
speciﬁcity in a future study. HSROC ¼ hierarchical summary receiver-operating
characteristic.
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245DISCUSS ION
Our study demonstrates that TCD detects intra-
cardiac RLS with a sensitivity of 97% and a speci-
ﬁcity of 93% when TEE is used as the reference.
TCD has an excellent LRþ of 14 and LR of 0.04,
making it a proﬁcient test to rule out or rule in RLS
in the stroke or migraine population (Fig. 7).
Increasing the microembolic threshold for a positive
TCD from 1 to 10 microbubbles increases the
speciﬁcity of TCD without compromising sensi-
tivity. This is the ﬁrst meta-analysis that assesses the
accuracy of TCD for detecting intracardiac RLS
compared with TEE as the reference. It is also the
ﬁrst meta-analysis that compares different protocols
of TCD for detecting intracardiac RLS.
In the evaluation of patients who may have a
PFO, several methods are available to determine
whether a RLS is present: TCD, transthoracic echo-
cardiography, TEE, or intracardiac echo. Although
TEE is considered the gold standard for diag-
nosing PFO (9,10), studies that compared TEE
with autopsy or intraoperative detection of PFO
demonstrated that the diagnosis is sometimes
missed by TEE (43,44). Studies that compared the
accuracy of TEE in the detection of PFO with
that of catheterization and/or surgery have de-
monstrated a sensitivity of 91% to 100% and ac-
curacy of 88% to 97% (45,46). Thus, our results
may have underestimated the sensitivity of TCD;
Spencer et al. (46) demonstrated a sensitivity of
98% and accuracy of 94% when TCD was com-
pared with PFO detection during catheterization
as the reference. In addition, some stroke patients
may have dysfunctional swallowing or poor coop-
eration, making TEE difﬁcult to perform, affecting
the test accuracy because of an inadequate Valsalva
maneuver. FN TEE tests may also be explained
by ineffective Valsalva secondary to sedation or by
the presence of the TEE probe in the patient’s
esophagus (37,47). Thus, the decreased speciﬁcity
of TCD may reﬂect some true shunts that are not
recognized by TEE.
Currently, TEE is often utilized when routine
diagnostics cannot identify a stroke etiology,
especially in young patients (48). However, TEE
may be uncomfortable and time-consuming for
some patients. Although unusual, severe compli-
cations such as esophageal bleeding or perforation
may occur. Contraindications of TEE such as
esophageal varices, Barrett’s esophagus, Zenker’s
diverticulum, esophageal or pharyngeal carcinoma,
strictures, Mallory-Weiss tears, or patients with a
serious bleeding risk make it important to have areliable alternative in contemporary clinical practice
(49).
TCD is an alternative method for indirectly
diagnosing PFO by assessing the presence of a
RLS. It employs the functional assessment of the
shunt using insonation of at least 1 MCA during a
venous injection bubble study and Valsalva ma-
neuver. Although intracardiac shunting through a
PFO is usually directed from the left atrium to the
right atrium, the release of the Valsalva maneuver
allows right atrial pressure to brieﬂy exceed left
atrial pressure, resulting in transient reversal of
ﬂow. After contrast injection, bubbles enter the
systemic circulation during this transient RLS,
resulting in microembolic signals in the cerebral
arteries that are detected by TCD. TCD utilizes a
pulsed Doppler transducer that detects the velocity
and intensity of cerebral arterial blood ﬂow by
spectral analysis. Although less common, color
duplex TCD may also be used in addition to
spectral TCD to conﬁrm the positivity of an exam;
4 of the included studies also utilized color TCD
(26,29,31,34). TCD provides good patient toler-
ance and excellent accuracies, making it a useful
alternative for detecting RLS in patients with
Table 3. Effect of Different Protocols on Sensitivity and Speciﬁcity of TCD
Parameter No. of Studies Sensitivity (95% CI) Speciﬁcity (95% CI)
Subanalysis 1a: saline contrast vs. Echovist contrast
Saline 12 0.98 (0.96–1.00) 0.91 (0.81–1.00)
Echovist 10 0.95 (0.91–0.99) 0.96 (0.90–1.00)
p Value 0.51 0.26
Subanalysis 1b: saline contrast vs. gelatin-based solution
Saline 12 0.98 (0.96–1.00) 0.91 (0.81–1.00)
Gelatin 4 0.94 (0.88–1.00) 0.95 (0.88–1.00)
p Value 0.37 0.16
Subanalysis 1c: gelatin-based solution vs. Echovist contrast
Gelatin 4 0.94 (0.88–1.00) 0.95 (0.88–1.00)
Echovist 10 0.95 (0.91–0.99) 0.96 (0.90–1.00)
p Value 0.06 0.58
Subanalysis 2: Valsalva maneuver vs. Valsalva maneuver with cough
VM 26 0.97 (0.95–0.99) 0.94 (0.89–0.99)
VM with cough 3 0.95 (0.89–1.00) 0.98 (0.94–1.00)
p Value 0.73 0.91
Subanalysis 3: 1 MB cutoff for positive TCD vs. 10 MB cutoff for positive TCD
1 MB 19 0.98 (0.96–1.00) 0.89 (0.82–0.96)
10 MB 3 0.97 (0.91–1.00) 1.00 (1.00–1.00)
p Value 0.29 0.04
Subanalysis 4: 1 MB cutoff for positive TEE vs. 3 MB cutoff for positive TEE
1 MB 16 0.96 (0.94–0.99) 0.88 (0.80–0.96)
3 MB 5 0.98 (0.96–1.00) 0.94 (0.86–1.00)
p Value 0.14 0.16
Subanalysis 5: provocation #5 s vs. provocation >5 s
#5 s 10 0.96 (0.93–0.99) 0.94 (0.85–1.00)
>5 s 7 0.98 (0.96–1.00) 0.92 (0.81–1.00)
p Value 0.50 0.52
Subanalysis 6: unilateral vs. bilateral MCA insonation
Unilateral 14 0.96 (0.93–0.99) 0.95 (0.89–1.00)
Bilateral 13 0.97 (0.95–1.00) 0.89 (0.79–0.99)
p Value 0.15 0.09
Abbreviations as in Tables 1 and 2.
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246stroke or migraine, or in patients being considered
for PFO closure.
It is thought that the accuracy of TCD can vary,
depending on the effectiveness of the provocative
maneuver, skill of the operator, location of the
intravenous needle, positioning of the ultrasound
probes, type of contrast, and the TCDmodel (Power
M-mode vs. single-gated TCDs). The Consensus
Conference of Venice outlined some key standards
for performing a TCD including the use of an
18-gauge needle in the cubital vein, preferable utili-
zation of agitated saline as the contrast, and appli-
cation of the Valsalva maneuver as the provocationmaneuver for more than 10 s (50). Although these
guidelines are based on data derived from observa-
tional studies before the year 2000, some differences
in methodology exist even now, depending on the
institution. In addition, the Consensus Conference
of Venice did not establish any microbubble num-
ber cutoff to deﬁne a positive TCD study. Ac-
cording to our sensitivity analysis, using a different
contrast agent, provocation maneuver, insonation of
unilateral versus bilateral MCAs, and a different
microbubble cutoff for a positive shunt with TEE
do not signiﬁcantly affect the accuracy of TCD.
However, increasing the TCD threshold for a
positive shunt from 1 microbubble to 10 micro-
bubbles signiﬁcantly increased the speciﬁcity of
TCD from 89% to 100% (p ¼ 0.04) without
affecting sensitivity (from 98% to 97%; p ¼ 0.29).
Our data support use of a higher microembolic
threshold for a positive shunt by TCD; this ﬁnding
is supported by previously published literature that
demonstrates that using a higher cutoff for a posi-
tive TCD, such as with the Spencer Logarithmic
Scale, which uses 30 microbubbles as a cutoff
instead of 1 microbubble, can decrease the number
of FP TCDs that occur because of clinically insig-
niﬁcant shunts (46). TCD has a higher sensitivity
than speciﬁcity as it is difﬁcult for a TCD to
differentiate between pulmonary and intracardiac
shunts, which may sometimes be misinterpreted on
a TEE as well. TCD does not show the operator
the anatomic position of the RLS, nor can it
distinguish between a PFO, an atrial septal defect,
or a pulmonary arteriovenous ﬁstula. Thus, patients
who have a clinical indication for PFO closure and
have a positive TCD may be sent to the catheter-
ization laboratory, where a TEE, or alternatively,
intracardiac echocardiography can be performed
before transcutaneous closure. For a suspected
pulmonary arteriovenous ﬁstula, a pulmonary artery
injection of echo contrast or a pulmonary angio-
gram may conﬁrm the diagnosis.
Study limitations. Of 29 included comparisons, 3
(10%) were not conducted in a blinded fashion; this
may have led to review bias in these particular
studies.
Another limitation of our review was the lack of
studies that utilized Power M-mode TCD. The
sensitivity of Power M-mode TCD has been
demonstrated to be higher than older single-gated
TCDs for the diagnosis of intracardiac RLS when
catheterization was used as the reference (46).
This study was also limited by the heterogeneity
of the included studies. In this meta-analysis, we
attempted to perform a sensitivity analysis on
Figure 7. Pre- and Post-Test Probabilities of Detecting an Intracardiac RLS With Transcranial Doppler
Shown are the probabilities of detecting a right-to-left shunt (RLS) in the general population assuming a 20% prevalence of RLS (A), and in
a population of patients with cryptogenic stroke or migraine assuming a 50% (B) to 55% (C) prevalence of RLS. A line from the pre-test
probability (Prior Prob) (ﬁrst axis) through the likelihood ratio (LR) (middle axis) to the post-test probability (last axis) was drawn. A person
testing positive with a pre-test probability (prevalence) of 20%, 50%, and 55% and a positive likelihood ratio of 14, will have a post-test
probability of 77%, 93%, and 94%, respectively; whereas a person testing negative, with the same pre-test probability and a negative
likelihood ratio of 0.04, would determine a post-test probability of 1%, 4%, and 4%, respectively. Continued on the next page.
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Figure 7. Continued
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248different protocols, where possible, to assess the
effect of changing the TCD protocol on accuracy of
the test. However, Hamann et al. (20) described 2
different accuracies of TCD by comparing contrast
injection through the antecubital versus the femoral
veins. We were unable to compare antecubital versus
femoral injection in this meta-analysis because of
the lack of other studies utilizing the femoral injec-
tion site. It has been reported that femoral injection
of agitated saline produces a higher sensitivity for the
detection of RLS using TCD (51).
CONCLUS IONS
TCD is a reliable, noninvasive alternative to TEE for
the diagnosis of RLS, with an excellent sensitivityand speciﬁcity of 97% and 93%, respectively.
Increasing the microembolic threshold for a positive
TCD from 1 microbubble to 10 microbubbles sig-
niﬁcantly improves the speciﬁcity of TCD without
compromising sensitivity. With a LRþ of 14 and
LR of 0.04, TCD is the test of choice for detecting
RLS through a PFO in patients with cryptogenic
stroke or migraine, having a post-test probability of
93% to 94% when testing positive, and a post-test
probability of 4% when testing negative.
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